We learned by way of the MariMed 10Q that a partne
Post# of 86989
(Total Views: 406)
Posted On: 11/26/2018 6:41:46 PM
We learned by way of the MariMed 10Q that a partnership agreement has been brokered between MariMed, Univec, and AGRiMED. Doctor David Dalton handled the negotiations for this deal, and it appears Univec will be the primary beneficiary of the deal. Details related to this deal will be forthcoming in press releases once Univec’s financials are completed. So how does this deal benefit investors in UNVC.
MariMed’s Vitiprints Proprietary Cannabis Printing Technology
* Platform creates new categories of precision dosed dissolvable cannabis products at efficiencies unsurpassed in the industry.
* Cannabis-infused medium enables rapid delivery sublingually, transdermally, or in liquid.
* The Vitiprints platform efficiently layers ingredients and graphic design, offering endless options for amazing customer products and experiences. In effect, MariMed’s Vitiprints technology will allow Univec to custom tailor products to every customer’s individual needs. This means custom logos can be printed along with specific doses and layers of cannabis molecular combinations targeting every imaginable medical ailment in varying dosages to meet individual needs.
“Our exclusive agreement with Vitiprints puts MariMed on the forefront of precision-dosed branded cannabis products and technology that will, above all, delight consumers with a revolutionary product category and experience,” said Robert Fireman, MariMed CEO. “This innovative technology enables creation of infused cannabis products which can be specifically designed for dosage, flavor, and supplements to achieve the desired effect or result. These products can be manufactured at speeds and efficiencies that will create cost savings for producers and consumers, while generating significant incremental revenue streams for MariMed from sales and sublicensing agreements.”
MariMed expects to complete test marketing of the dissolvable product sets in a MariMed-managed facility within 90 days (announced in August and this brings us to December), then launch in legal states across the country, and finally expand worldwide via sublicense agreements with qualified manufacturers and distributors. Products will be available on shelves as early as the end of Q4 2018.
“Vitiprints is ideally suited and ‘future proof’ against the widely differing and ever-changing cannabis regulations regarding dosing, formulation and appearance, enabling instant modification via the user interface versus a complete product redesign,” said Ryan Crandall, MariMed VP of Brand and Licensing.
“Furthermore, we are able to engage customers by using printed design layers as a touch point into our customer education and engagement portal, in turn generating loyalty and feedback. It’s a dream come true for product development and marketing teams,” Crandall added.
https://globenewswire.com/news-release/2018/0...ology.html
MariMed’s Vitiprints Proprietary Cannabis Printing Technology
* Platform creates new categories of precision dosed dissolvable cannabis products at efficiencies unsurpassed in the industry.
* Cannabis-infused medium enables rapid delivery sublingually, transdermally, or in liquid.
* The Vitiprints platform efficiently layers ingredients and graphic design, offering endless options for amazing customer products and experiences. In effect, MariMed’s Vitiprints technology will allow Univec to custom tailor products to every customer’s individual needs. This means custom logos can be printed along with specific doses and layers of cannabis molecular combinations targeting every imaginable medical ailment in varying dosages to meet individual needs.
“Our exclusive agreement with Vitiprints puts MariMed on the forefront of precision-dosed branded cannabis products and technology that will, above all, delight consumers with a revolutionary product category and experience,” said Robert Fireman, MariMed CEO. “This innovative technology enables creation of infused cannabis products which can be specifically designed for dosage, flavor, and supplements to achieve the desired effect or result. These products can be manufactured at speeds and efficiencies that will create cost savings for producers and consumers, while generating significant incremental revenue streams for MariMed from sales and sublicensing agreements.”
MariMed expects to complete test marketing of the dissolvable product sets in a MariMed-managed facility within 90 days (announced in August and this brings us to December), then launch in legal states across the country, and finally expand worldwide via sublicense agreements with qualified manufacturers and distributors. Products will be available on shelves as early as the end of Q4 2018.
“Vitiprints is ideally suited and ‘future proof’ against the widely differing and ever-changing cannabis regulations regarding dosing, formulation and appearance, enabling instant modification via the user interface versus a complete product redesign,” said Ryan Crandall, MariMed VP of Brand and Licensing.
“Furthermore, we are able to engage customers by using printed design layers as a touch point into our customer education and engagement portal, in turn generating loyalty and feedback. It’s a dream come true for product development and marketing teams,” Crandall added.
https://globenewswire.com/news-release/2018/0...ology.html
(2)
(0)